The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.78BCNY
717.54M · vs all stocks (USD)
Updated Nov 19, 2026
Revenue (TTM)
411.17MCNY
61.67M · vs all stocks (USD)
Updated Nov 19, 2026
Profit Margin
-58.97%
vs Specialty Business Services peers
Updated Nov 19, 2026
Beta
-0.3400x
vs all stocks
Updated Nov 19, 2026
52-Week Change
-38.30%
vs all stocks
Updated Nov 19, 2026
Market Capitalization
4.78BCNY
717.54M · vs all stocks (USD)
Updated Nov 19, 2026
Enterprise Value
5.25BCNY
787.95M · vs all stocks (USD)
Updated Nov 19, 2026
Forward P/E
125.75x
vs Specialty Business Services peers
Updated Nov 19, 2026
Price to Sales (TTM)
12.07x
vs Specialty Business Services peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 11.64×.Updated Nov 19, 2026
Price to Book (MRQ)
4.83x
vs Specialty Business Services peers
Updated Nov 19, 2026
Enterprise to Revenue
12.78x
vs Specialty Business Services peers
Updated Nov 19, 2026
Enterprise to EBITDA
-52.92x
vs Specialty Business Services peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 65.91×.Updated Nov 19, 2026
Gross Margin
21.92%
vs Specialty Business Services peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 7.62%.Updated Nov 19, 2026
Profit Margin
-58.97%
vs Specialty Business Services peers
Updated Nov 19, 2026
Operating Margin
-38.09%
vs Specialty Business Services peers
Updated Nov 19, 2026
Return on Assets (TTM)
-4.53%
vs Specialty Business Services peers
Updated Nov 19, 2026
Return on Equity (TTM)
-18.84%
vs Specialty Business Services peers
Updated Nov 19, 2026
Revenue (TTM)
411.17MCNY
61.67M · vs all stocks (USD)
Updated Nov 19, 2026
Revenue per Share (TTM)
0.8330CNYUpdated Nov 19, 2026
Quarterly Revenue Growth
1.30%
vs Specialty Business Services peers
Updated Nov 19, 2026
Gross Profit (TTM)
31.35MCNY
4.70M · vs all stocks (USD)
Updated Nov 19, 2026
EBITDA (TTM)
79.70MCNY
11.95M · vs all stocks (USD)
Updated Nov 19, 2026
Net Income (TTM)
-242.48MCNY
-36.37M · vs all stocks (USD)
Updated Nov 19, 2026
Quarterly Earnings Growth (YoY)
-85.45%
vs Specialty Business Services peers
Updated Nov 19, 2026
Operating Cash Flow (TTM)
-153.26MCNY
-22.99M · vs all stocks (USD)
Updated Nov 19, 2026
Levered Free Cash Flow (TTM)
-122.82MCNY
-18.42M · vs all stocks (USD)
Updated Nov 19, 2026
5-Year Average Dividend Yield
0.36%
vs all stocks
Updated Nov 19, 2026
Payout Ratio
0.00%
vs Specialty Business Services peers
Updated Nov 19, 2026
Minority Interest (Equity)
87.67MCNYFY2025 · Dec 31, 2025
Revenue
1.01BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
837.36MCNYFY2025 · Dec 31, 2025
Gross Profit
175.92MCNYFY2025 · Dec 31, 2025
Operating Income
-6.56MCNY
-983.28K · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-145.57MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-7.85MCNYFY2025 · Dec 31, 2025
Net Income
-137.72MCNYFY2025 · Dec 31, 2025
EBIT
-114.74MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
79.70MCNYFY2025 · Dec 31, 2025
Research & Development
34.24MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
54.86MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
10.11MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
2.36MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
30.83MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.2956CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.2956CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
493.26MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
493.26MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-137.72MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-8.08MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
517.59MCNYFY2025 · Dec 31, 2025
Free Cash Flow
504.53MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
432.04MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-137.72MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
32.67MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
4.28MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
618.36MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-13.06MCNYFY2025 · Dec 31, 2025
Net Acquisitions
0.00CNYFY2025 · Dec 31, 2025
Purchase of Investments
-324.38MCNYFY2025 · Dec 31, 2025
Sale of Investments
346.99MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
9.56MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
395.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-368.47MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-23.84MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-49.77MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-47.08MCNYFY2025 · Dec 31, 2025
Shares Outstanding
496.19MSharesUpdated Nov 19, 2026
Float Shares
484.84MSharesUpdated Nov 19, 2026
% Held by Insiders
2.51%
vs all stocks
Updated Nov 19, 2026
% Held by Institutions
0.79%
vs all stocks
Updated Nov 19, 2026
Total Cash (MRQ)
324.70MCNY
48.70M · vs all stocks (USD)
Updated Nov 19, 2026
Total Cash per Share (MRQ)
0.6580CNYUpdated Nov 19, 2026
Total Debt (MRQ)
443.16MCNY
66.47M · vs all stocks (USD)
Updated Nov 19, 2026
Total Debt to Equity (MRQ)
0.3968x
vs Specialty Business Services peers
Updated Nov 19, 2026
Current Ratio (MRQ)
1.62x
vs Specialty Business Services peers
Updated Nov 19, 2026
Book Value per Share (MRQ)
2.08CNYUpdated Nov 19, 2026
Total Assets
2.16BCNY
323.52M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
987.35MCNYFY2025 · Dec 31, 2025
Total Liabilities
966.90MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.17BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
216.81MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
750.09MCNYFY2025 · Dec 31, 2025
Cash
431.39MCNYFY2025 · Dec 31, 2025
Cash Equivalents
42.04MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
473.42MCNYFY2025 · Dec 31, 2025
Accounts Receivable
236.91MCNYFY2025 · Dec 31, 2025
Inventory
136.68MCNYFY2025 · Dec 31, 2025
Accounts Payable
180.38MCNYFY2025 · Dec 31, 2025
Short-term Debt
374.55MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
3.55MCNYFY2025 · Dec 31, 2025
Long-term Debt
95.05MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
30.14MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
496.19MCNYFY2025 · Dec 31, 2025
Retained Earnings
-283.80MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.19BCNY
178.50M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
10.34MCNYFY2025 · Dec 31, 2025
52-Week Low
8.53CNYUpdated Nov 19, 2026
52-Week High
20.18CNYUpdated Nov 19, 2026
52-Week Change
-38.30%
vs all stocks
Updated Nov 19, 2026
Beta
-0.3400x
vs all stocks
Updated Nov 19, 2026
50-Day MA
10.02CNYUpdated Nov 19, 2026
200-Day MA
13.35CNYUpdated Nov 19, 2026
Avg 10-Day Volume
36.67MSharesUpdated Nov 19, 2026
Avg 30-Day Volume
22.38MSharesUpdated Nov 19, 2026
Diluted EPS (TTM)
-0.4900CNYUpdated Nov 19, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -38.1%, lower than 95% of its Specialty Business Services peers (median 11.3%)Significant